AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness
Publication
, Conference
Llanga, TA; Miyadera, K; Conatser, L; Gilger, B; Kurtzberg, J; Samulski, RJ; Hirsch, M
Published in: MOLECULAR THERAPY
April 22, 2019
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2019
Volume
27
Issue
4
Start / End Page
441 / 442
Location
Washington, DC
Publisher
CELL PRESS
Conference Name
22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Llanga, T. A., Miyadera, K., Conatser, L., Gilger, B., Kurtzberg, J., Samulski, R. J., & Hirsch, M. (2019). AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness. In MOLECULAR THERAPY (Vol. 27, pp. 441–442). Washington, DC: CELL PRESS.
Llanga, Telmo A., Keiko Miyadera, Laura Conatser, Brian Gilger, Joanne Kurtzberg, Richard J. Samulski, and Matthew Hirsch. “AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness.” In MOLECULAR THERAPY, 27:441–42. CELL PRESS, 2019.
Llanga TA, Miyadera K, Conatser L, Gilger B, Kurtzberg J, Samulski RJ, et al. AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 441–2.
Llanga, Telmo A., et al. “AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness.” MOLECULAR THERAPY, vol. 27, no. 4, CELL PRESS, 2019, pp. 441–42.
Llanga TA, Miyadera K, Conatser L, Gilger B, Kurtzberg J, Samulski RJ, Hirsch M. AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness. MOLECULAR THERAPY. CELL PRESS; 2019. p. 441–442.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2019
Volume
27
Issue
4
Start / End Page
441 / 442
Location
Washington, DC
Publisher
CELL PRESS
Conference Name
22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics